Compare Novartis AG (NVS) vs Plby Group Inc (PLBY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Plby Group Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Plby Group Inc trades at $1.21 (market cap $139.87M). The key difference: Novartis AG is far larger — about 2075.1× Plby Group Inc's market cap, and Novartis AG pays a 3.17% dividend while Plby Group Inc pays none. Which is the better fit depends on your goals.
| NVS | PLBY | |
|---|---|---|
Market Cap | $290.25B | $139.87M |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $2.71 |
52-Week Low | $113.50 | $1.11 |
Enterprise Value | $330.27B | $287.68M |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Plby Group Inc
PLBY Group Inc is a pleasure and leisure company. The company's segment includes Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It generates maximum revenue from the Direct-to-Consumer segment. Direct-to-Consumer operations include consumer products sold through third-party retailers or online direct-to-customer. Geographically, it derives a majority of revenue from the United States.
Read more on PLBY →
